Literature DB >> 10618091

Distribution of the intermedilysin gene among the anginosus group streptococci and correlation between intermedilysin production and deep-seated infection with Streptococcus intermedius.

H Nagamune1, R A Whiley, T Goto, Y Inai, T Maeda, J M Hardie, H Kourai.   

Abstract

The distribution of intermedilysin, a human-specific cytolysin, among the anginosus group streptococci and the correlation of toxin production and infection by Streptococcus intermedius were investigated. PCR and Southern hybridization specific for the intermedilysin gene revealed that the toxin gene exists only in S. intermedius and no homologue to the toxin gene is distributed in S. anginosus and S. constellatus. Thus, the intermedilysin gene is useful as a marker gene of S. intermedius. Moreover, a human-specific hemolysis assay and Western blotting with intermedilysin-specific antibodies clearly demonstrated that the intermedilysin production level in isolates from deep-seated infections, such as brain and liver abscesses, is higher (6.2- to 10.2-fold, respectively) than in strains from normal habitats, such as dental plaque, or from peripheral infection sites. However, other candidate virulence factors of S. intermedius, such as chondroitin sulfate depolymerase, hyaluronidase, and sialidase activities, did not show such a clear correlation between enzymatic activity and isolation sites or disease severity. From these results, intermedilysin is likely to be the pathogenic or triggering factor of significance in inducing deep-seated infections with S. intermedius.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618091      PMCID: PMC88699          DOI: 10.1128/JCM.38.1.220-226.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Protective effect of a T-cell-dependent immunosuppressive, B-cell-mitogenic protein (F3'EP-Si, or P90) produced by Streptococcus intermedius.

Authors:  M Lima; A Bandeira; D Portnoi; A Ribeiro; M A Chaves
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

2.  Sialidase activity of the "Streptococcus milleri group" and other viridans group streptococci.

Authors:  D Beighton; R A Whiley
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

3.  Classification and overview of the genera Streptococcus and Enterococcus.

Authors:  J M Hardie; R A Whiley
Journal:  J Appl Microbiol       Date:  1997-10       Impact factor: 3.772

Review 4.  Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen.

Authors:  K L Ruoff
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

5.  A study of small-colony, beta-haemolytic, Lancefield group C streptococci within the anginosus group: description of Streptococcus constellatus subsp. pharyngis subsp. nov., associated with the human throat and pharyngitis.

Authors:  R A Whiley; L M Hall; J M Hardie; D Beighton
Journal:  Int J Syst Bacteriol       Date:  1999-10

6.  Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus strains within the "Streptococcus milleri group".

Authors:  R A Whiley; H Fraser; J M Hardie; D Beighton
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

7.  Proteolytic activity of oral streptococci.

Authors:  K A Homer; R A Whiley; D Beighton
Journal:  FEMS Microbiol Lett       Date:  1990-02       Impact factor: 2.742

8.  Heterogeneity among 16S-23S rRNA intergenic spacers of species within the 'Streptococcus milleri group'.

Authors:  R A Whiley; B Duke; J M Hardie; L M C Hall
Journal:  Microbiology (Reading)       Date:  1995-06       Impact factor: 2.777

9.  Monoclonal antibody to Streptococcus mutans type e cell wall polysaccharide antigen.

Authors:  H Kato; F Ota; K Fukui; K Yagawa
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

10.  Emended descriptions and recognition of Streptococcus constellatus, Streptococcus intermedius, and Streptococcus anginosus as distinct species.

Authors:  R A Whiley; D Beighton
Journal:  Int J Syst Bacteriol       Date:  1991-01
View more
  27 in total

1.  Effect on polymorphonuclear cell function of a human-specific cytotoxin, intermedilysin, expressed by Streptococcus intermedius.

Authors:  M G Macey; R A Whiley; L Miller; H Nagamune
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  Insights into the action of the superfamily of cholesterol-dependent cytolysins from studies of intermedilysin.

Authors:  Galina Polekhina; Kara Sue Giddings; Rodney K Tweten; Michael W Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-06       Impact factor: 11.205

Review 3.  Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins.

Authors:  Rodney K Tweten
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Identification and characterization of a novel secreted glycosidase with multiple glycosidase activities in Streptococcus intermedius.

Authors:  Hidenori Imaki; Toshifumi Tomoyasu; Naoki Yamamoto; Chiharu Taue; Sachiko Masuda; Ayuko Takao; Nobuko Maeda; Atsushi Tabata; Robert A Whiley; Hideaki Nagamune
Journal:  J Bacteriol       Date:  2014-05-23       Impact factor: 3.490

5.  Role of catabolite control protein A in the regulation of intermedilysin production by Streptococcus intermedius.

Authors:  Toshifumi Tomoyasu; Atsushi Tabata; Riki Hiroshima; Hidenori Imaki; Sachiko Masuda; Robert A Whiley; Joseph Aduse-Opoku; Ken Kikuchi; Keiichi Hiramatsu; Hideaki Nagamune
Journal:  Infect Immun       Date:  2010-07-12       Impact factor: 3.441

6.  Double jeopardy - concurrent lung abscess and pleural empyema.

Authors:  A Schattner; I Dubin; M Gelber
Journal:  QJM       Date:  2016-05-19

7.  Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis.

Authors:  Margot E Grinwis; Christopher D Sibley; Michael D Parkins; Christina S Eshaghurshan; Harvey R Rabin; Michael G Surette
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

8.  Intermedilysin-receptor interactions during assembly of the pore complex: assembly intermediates increase host cell susceptibility to complement-mediated lysis.

Authors:  Stephanie LaChapelle; Rodney K Tweten; Eileen M Hotze
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

9.  Genotyping by amplified fragment length polymorphism analysis reveals persistence and recurrence of infection with Streptococcus anginosus group organisms.

Authors:  Jan A Jacobs; Jeroen H T Tjhie; Monique G J Smeets; Corrie S Schot; Leo M Schouls
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Identification of the high affinity binding site in the Streptococcus intermedius toxin intermedilysin for its membrane receptor, the human complement regulator CD59.

Authors:  Timothy R Hughes; Kirsty S Ross; Graeme J M Cowan; Baalasubramanian Sivasankar; Claire L Harris; Timothy J Mitchell; B Paul Morgan
Journal:  Mol Immunol       Date:  2009-02-06       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.